Cargando…
Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms: A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Vascular endothelial growth factor (VEGF) is produced either as a pro-angiogenic or anti-angiogenic protein depending upon splice site choice in the terminal, eighth exon. Proximal splice site selection (PSS) in exon 8 generates pro-angiogenic isoforms such as VEGF(165), and distal splice site selec...
Autores principales: | Nowak, Dawid G., Amin, Elianna Mohamed, Rennel, Emma S., Hoareau-Aveilla, Coralie, Gammons, Melissa, Damodoran, Gopinath, Hagiwara, Masatoshi, Harper, Steven J., Woolard, Jeanette, Ladomery, Michael R., Bates, David O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820781/ https://www.ncbi.nlm.nih.gov/pubmed/19906640 http://dx.doi.org/10.1074/jbc.M109.074930 |
Ejemplares similares
-
The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
por: Rennel, E S, et al.
Publicado: (2008) -
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
por: Carter, James G., et al.
Publicado: (2014) -
Utp23p is required for dissociation of snR30 small nucleolar RNP from preribosomal particles
por: Hoareau-Aveilla, Coralie, et al.
Publicado: (2012) -
Mammalian HCA66 protein is required for both ribosome synthesis and centriole duplication
por: Bonnart, Chrystelle, et al.
Publicado: (2012) -
Alternative splicing of TIA‐1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance
por: Hamdollah Zadeh, Maryam A., et al.
Publicado: (2014)